Biofunctional hydrogels for skeletal muscle constructs

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 11, 2016, Pages 967-976

  Salimath, Apoorva S ^a   García, Andrés J ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

biomaterial; microenvironment; myoblast; myogenic differentiation; repair; sarcomeric myosin

Indexed keywords

BIOMATERIALS; CELLS; COPYRIGHTS; CYTOLOGY; MUSCLE; PEPTIDES; POLYETHYLENE GLYCOLS; SCAFFOLDS (BIOLOGY);

BIOFUNCTIONAL; FUNCTIONALIZED; HYDROGEL SCAFFOLDS; MICROENVIRONMENTS; MUSCLE TISSUES; MYOBLASTS; MYOGENIC DIFFERENTIATIONS; SARCOMERIC MYOSIN; SKELETAL MUSCLE; SKELETAL MUSCLE CELLS;

HYDROGELS;

MACROGOL; MALEIMIDE; ARGINYL-GLYCYL-ASPARTIC ACID; MACROGOL 400; MACROGOL DERIVATIVE; OLIGOPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HYDROGEL; LIMIT OF QUANTITATION; MOLECULAR WEIGHT; MOUSE; MULTINUCLEAR CELL; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL; ANIMAL; CELL LINE; CHEMISTRY; CYTOLOGY; METABOLISM; MUSCLE DEVELOPMENT;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; HYDROGELS; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS;

EID: 84894415300     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1881     Document Type: Article

References (41)

1. Bach AD, Beier JP, Stern-Staeter J et al. 2004. Skeletal muscle tissue engineering. J Cell Mol Med 8: 413–422.
2. Bajaj P, Reddy B Jr, Millet L et al. 2011. Patterning the differentiation of C2C12 skeletal myoblasts. Integ Biol 3: 897–909.
3. Barton ER, Lynch G, Khurana TS. 2008. Measuring isometric force of isolated mouse muscles in vitro. Washington, DC: http://www.treat-nmd.eu/downloads/file/sops/dmd/MDX/DMD_M.1.2.002.pdf.
4. Buck CA, Horwitz AF. 1987. Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol 3: 179–205.
5. Charge SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209–238.
6. Charrasse S, Meriane M, Comunale F et al. 2002. N-cadherin-dependent cell–cell contact regulates Rho GTPases and β-catenin localization in mouse C2C12 myoblasts. J Cell Biol 158: 953–965.
7. Cheng AY, Garcia AJ. 2013. Engineering the matrix microenvironment for cell delivery and engraftment for tissue repair. Curr Opin Biotechnol 24: 864–871.
8. Dennis RG, Kosnik PE II, Gilbert ME et al. 2001. Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines. Am J Physiol Cell Physiol 280: C288–295.
9. DiEdwardo CA, Petrosko P, Acarturk TO et al. 1999. Muscle tissue engineering. Clin Plastic Surg 26: 647–656, ix–x.
10. Engler AJ, Griffin MA, Sen S et al. 2004. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 166: 877–887.
11. Fujita H, Shimizu K, Nagamori E. 2009. Novel method for fabrication of skeletal muscle construct from the C2C12 myoblast cell line using serum-free medium AIM-V. Biotechnol Bioeng 103: 1034–1041.
12. García AJ, Vega MD, Boettiger D. 1999. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 10: 785–798.
13. Grogan BF, Hsu JR. 2011. Volumetric muscle loss. J Am Acad Orthop Surg 19: S35–37.
14. Hill E, Boontheekul T, Mooney DJ. 2006. Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng 12: 1295–1304.
15. Hinds S, Bian W, Dennis RG et al. 2011. The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials 32: 3575–3583.
16. Huijing PA. 1999. Muscle as a collagen fiber reinforced composite: a review of force transmission in muscle and whole limb. J Biomech 32: 329–345.
17. Janmey PA, Winer JP, Weisel JW. 2009. Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6: 1–10.
18. Kamm RD, Bashir R. 2013. Creating living cellular machines. Ann Biomed Eng (in press).
19. Kroehne V, Heschel I, Schügner F et al. 2008. Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med 12: 1640–1648.
20. Lawson MA, Purslow PP. 2000. Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs 167: 130–137.
21. Marquette ML, Byerly D, Sognier M. 2007. A novel in vitro three-dimensional skeletal muscle model. In Vitro Cell Dev Biol Anim 43: 255–263.
22. Mase VJ Jr, Hsu JR, Wolf SE et al. 2010. Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics 33: 511.
23. Miller JB, Everitt EA, Smith TH et al. 1993. Cellular and molecular diversity in skeletal muscle development: news from in vitro and in vivo. Bioessays 15: 191–196.
24. Miller JS, Bhatia SN, Christopher CS et al. 2012. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater 11: 768–774.
25. Page RL, Malcuit C, Vilner L et al. 2011. Restoration of skeletal muscle defects with adult human cells delivered on fibrin microthreads. Tissue Eng A 17: 2629–2640.
26. Patterson J, Hubbell JA. 2010. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials 31: 7836–7845.
27. Pedrotty DM, Koh J, Davis BH et al. 2005. Engineering skeletal myoblasts: roles of three-dimensional culture and electrical stimulation. Am J Physiol Heart Circ Physiol 288: H1620–1626.
28. Phelps EA, Enemchukwu NO, Fiore VF et al. 2012. Maleimide crosslinked bioactive PEG hydrogel exhibits improved reaction kinetics and crosslinking for cell encapsulation and in situ delivery. Adv Mater 24: 64–70.
29. Phelps EA, Headen DM, Taylor WR et al. 2013. Vasculogenic biosynthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. Biomaterials 34: 4602–4611.
30. Phelps EA, Landazuri N, Thule PM et al. 2010. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci 107: 3323–3328.
31. Purslow PP. 2002. The structure and functional significance of variations in the connective tissue within muscle. Comp Biochem Phys A 133: 947–966.
32. Raab M, Shin JW, Discher DE. 2010. Matrix elasticity in vitro controls muscle stem cell fate in vivo. Stem Cell Res Ther 1: 38.
33. Raeber GP, Lutolf MP, Hubbell JA. 2005. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 89: 1374–1388.
34. Rowley JA, Mooney DJ. 2002. Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res 60: 217–223.
35. Salimath AS, Phelps EA, Boopathy AV et al. 2012. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One 7: e50980.
36. Takahashi H, Shimizu T, Nakayama M et al. 2013. The use of anisotropic cell sheets to control orientation during the self-organization of 3D muscle tissue. Biomaterials 34: 7372–7380.
37. Thorsteinsdottir S, Deries M, Cachaco AS et al. 2011. The extracellular matrix dimension of skeletal muscle development. Dev Biol 354: 191–207.
38. Turner NJ, Badylak SF. 2012. Regeneration of skeletal muscle. Cell Tissue Res 347: 759–774.
39. Wang PY, Thissen H, Tsai WB. 2012. The roles of RGD and grooved topography in the adhesion, morphology, and differentiation of C2C12 skeletal myoblasts. Biotechnol Bioeng 109: 2104–2115.
40. Yaffe D, Saxel O. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725–727.
41. Zhao Y, Zeng H, Nam J et al. 2009. Fabrication of skeletal muscle constructs by topographic activation of cell alignment. Biotechnol Bioeng 102: 624–631.